A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines.Laura Sepp‐Lorenzino, Neal Rosen, Zhuang Ma et al.|PubMed|1995Cited by 385
Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilonesMark M. Moasser, Neal Rosen, Laura Sepp‐Lorenzino et al.|Proceedings of the National Academy of Sciences|1998Cited by 210
Discovery and Characterization of a Cell-Permeable, Small-Molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding SiteJingsong Yang, Allen Oliff, Nino Campobasso et al.|Chemistry & Biology|2011Cited by 120
Farnesyltransferase inhibitors and anti-Ras therapyW. Wayt Gibbs, Allen Oliff, Nancy E. Kohl et al.|Breast Cancer Research and Treatment|1996Cited by 42
Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancerLaura Sepp‐Lorenzino, HI Scher, G Tjaden et al.|Prostate Cancer and Prostatic Diseases|2001Cited by 25